DETROIT Generic drug maker Caraco said that its interim CEO and director, Jitendra Doshi, will step down from his position Nov. 1 due to personal and health-related reasons.
While Doshi will assist the company in effecting a smooth transition, G. P. Singh will assume the position of CEO, Caraco said. Singh currently serves as Caraco's COO, and previously was SVP business strategies for three years.
